Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trial
Citation
Cuzick , J , Sestak , I , Forbes , J F , Dowsett , M , Knox , J , Cawthorn , S , Saunders , C , Roche , N , Mansel , R E , von Minckwitz , G , Bonanni , B , Palva , T , Howell , A & IBIS-II investigators 2014 , ' Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trial ' , The Lancet , vol. 383 , no. 9922 , pp. 1041-1048 . https://doi.org/10.1016/S0140-6736(13)62292-8
Rights
© Cuzick et al. Open Access article distributed under the terms of CC BY https://creativecommons.org/licenses/by/3.0/